Although patients with oligodendroglioma (median 35.0%; p = 0.066) and astrocytoma (median 39.5%; p = 0.085) also exhibited reduced proportions of CD3+/CD4+ helper T cells compared to the healthy control cohort, these differences did not reach statistical significance. This evidence concerns the gene CD4 and astrocytoma (excluding glioblastoma).